Back to Search
Start Over
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake
- Source :
- Cancer Biotherapy and Radiopharmaceuticals
- Publication Year :
- 2007
-
Abstract
- The aim of this study was to comparatively investigate the effects of 5-azacytidine-C (5-Aza), trichostatin-A (TSA), and all-trans retinoic acid (ATRA) on the mRNA expressions of the sodium and iodine (Na/I) symporter (NIS), thyroglobulin (Tg), thyroid peroxidase (TPO), and the thyroid-stimulating hormone receptor (TSH-R), as well as radioiodine (RAI) uptake in cancer (B-CPAP) and normal (Nthy-ori 3-1) thyroid cell lines. Cell lines were treated with 10 ng/mL of TSA, 5 μM of 5-AZA, and 1 μM of ATRA, according to the MTT (methyl-thiazol-tetrazolium) test results. Additionally, recombinant thyroid-stimulating hormone (rTSH) was also applied, with a selected dose of 100 ng/mL. Following the treatment, NIS, Tg, TPO, and TSH-R mRNA levels were detected by real-time-polymerase chain reaction (RT-PCR) and RAI uptakes were measured by using a well counter as counts/cell number. 5-Aza increased TSH-R mRNA expression in both of the cell lines and decreased TPO, NIS, and Tg mRNA levels in the cancer cell line. In the normal thyroid cell line, 5-AZA increased TPO mRNA levels by 2-fold and made no differences in NIS and Tg mRNA levels. TSA treatment repressed NIS and Tg mRNA levels and made no change on other thyroid-specific genes that were investigated in the cancer cell line. In the normal thyroid cell line, TSA increased TSH-R mRNA levels in 72 hours and created no important difference in the other genes. ATRA repressed the TSH-R mRNA levels in the normal thyroid cell line and increased the TPO and Tg mRNA levels slightly in both the cell lines. Furthermore, in short-term treatment, ATRA repressed the NIS gene expression slightly, but in the long term, this repression turned to basal levels. 5-Aza, TSA, and ATRA did not make any changes in RAI uptake in the cancer cell line, but rTSH increased RAI uptake significantly. In the normal thyroid cell line, TSA and ATRA decreased RAI uptake (to 1/10 and 1/2, respectively), but 5-Aza and rTSH increased RAI uptake significantly (2- and 4-fold, respectively). In our study, we showed an increase in TSH-R gene expression and radioiodine uptake with 5-Aza. Further in vitro and in vivo studies are needed to support our findings and the potential clinical use of this agent. © Mary Ann Liebert, Inc.
- Subjects :
- Male
Cancer Research
Time Factors
medicine.medical_treatment
radioactive iodine
thyroid peroxidase
Thyroid Gland
Apoptosis
cancer cell culture
thyroglobulin
trichostatin A
Hydroxamic Acids
Polymerase Chain Reaction
Iodine Radioisotopes
cotransporter
drug uptake
retinoic acid
RNA, Neoplasm
comparative study
conference paper
5-Azacytidine-c
biology
Chemistry
messenger RNA
Thyroid
Sodium iodide symporter
Receptors, Thyrotropin
General Medicine
gene expression regulation
unclassified drug
medicine.anatomical_structure
Oncology
priority journal
Hormone receptor
Azacitidine
medicine.drug
Sodium-iodide symporter
medicine.medical_specialty
endocrine system
azacitidine
mRNA
Tretinoin
Iodide Peroxidase
TPO
reverse transcription polymerase chain reaction
radioisotope distribution
Thyroid peroxidase
Internal medicine
Cell Line, Tumor
medicine
Humans
Radiology, Nuclear Medicine and imaging
controlled study
human
RNA, Messenger
Thyroid Neoplasms
neoplasms
protein expression
thyroid cell
Aged
Pharmacology
human cell
Proteins
NIS
thyrotropin receptor
Endocrinology
Trichostatin A
radiobiology
Gene Expression Regulation
Cell culture
biology.protein
Thyroglobulin
sodium iodine cotransporter
Recombinant thyrotropin
Hormone
Subjects
Details
- ISSN :
- 10849785
- Volume :
- 22
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Cancer biotherapyradiopharmaceuticals
- Accession number :
- edsair.doi.dedup.....c37ebc1ebd61258eaafc62694fc57139